IRIS
RIA, ROBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.446
EU - Europa 2.263
AS - Asia 1.008
AF - Africa 5
OC - Oceania 4
SA - Sud America 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 13.731
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.443
SE - Svezia 777
CN - Cina 772
IT - Italia 375
DE - Germania 292
UA - Ucraina 253
FI - Finlandia 186
GB - Regno Unito 161
SG - Singapore 79
FR - Francia 66
BE - Belgio 51
IN - India 50
VN - Vietnam 40
IE - Irlanda 39
CZ - Repubblica Ceca 29
HK - Hong Kong 25
JP - Giappone 19
PL - Polonia 8
RU - Federazione Russa 7
IR - Iran 6
NL - Olanda 5
EG - Egitto 4
KR - Corea 4
AU - Australia 3
CA - Canada 3
ES - Italia 3
TR - Turchia 3
TW - Taiwan 3
CH - Svizzera 2
CL - Cile 2
EU - Europa 2
HU - Ungheria 2
MK - Macedonia 2
TH - Thailandia 2
AZ - Azerbaigian 1
BR - Brasile 1
IL - Israele 1
IQ - Iraq 1
LB - Libano 1
LT - Lituania 1
LU - Lussemburgo 1
MW - Malawi 1
NZ - Nuova Zelanda 1
PH - Filippine 1
RO - Romania 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 13.731
Salva come PNG Salva come JPEG
Città #
Fairfield 1.541
Chandler 1.156
Woodbridge 1.070
Ashburn 767
Houston 660
Seattle 633
Nyköping 601
Jacksonville 581
Cambridge 561
Wilmington 505
Ann Arbor 482
Lawrence 215
New York 213
Roxbury 212
Nanjing 203
Beijing 158
Bari 134
Des Moines 133
Inglewood 111
Princeton 105
Boardman 76
San Diego 62
Nanchang 57
Singapore 55
Brussels 51
Shenyang 51
Helsinki 45
Los Angeles 44
Brooklyn 42
Dearborn 42
Dong Ket 40
Dublin 39
Jiaxing 37
Rome 32
Hebei 31
London 30
Munich 29
Brno 28
Leawood 27
Pune 26
Marseille 25
Tianjin 25
Washington 23
Grafing 20
Guangzhou 20
Changsha 18
Paris 17
Osaka 16
Augusta 15
Redwood City 15
Jinan 14
Kunming 14
Zhengzhou 14
Falls Church 12
Florence 11
San Mateo 8
Shanghai 8
Taizhou 8
Kilburn 7
Monmouth Junction 7
Wuhan 7
Wuxi 7
Ardabil 6
Brescia 6
Hefei 6
Islington 6
Milan 6
Mumbai 6
Ningbo 6
Tappahannock 6
Norwalk 5
Nürnberg 5
Prescot 5
Acton 4
Alcamo 4
Aragona 4
Auburn Hills 4
Bengaluru 4
Chicago 4
Chiswick 4
Hounslow 4
Messina 4
New Bedfont 4
Palermo 4
Parma 4
Radomsko 4
Shenzhen 4
Verona 4
Cutrofiano 3
Detroit 3
Fuzhou 3
Hong Kong 3
Istanbul 3
Jinhua 3
New Delhi 3
Obrigheim 3
Phoenix 3
Suri 3
Adelfia 2
Aversa 2
Totale 11.353
Salva come PNG Salva come JPEG
Nome #
Adhesion-Mediated Multiple Myeloma (MM) Disease Progression: Junctional Adhesion Molecule a Enhances Angiogenesis and Multiple Myeloma Dissemination and Predicts Poor Survival 222
Central Function for JAM-a in Multiple Myeloma Patients with Extramedullary Disease. 139
Bone marrow endothelial cells sustain a tumor-specific CD8+ T cell subset with suppressive function in myeloma patients 128
Extramedullary Plasmacytoma Mimicking Pancreatic Cancer: An Unusual Presentation 125
Four proteins governing overangiogenic endothelial cell phenotype in patients with multiple myeloma are plausible therapeutic targets 117
Involvement of NOTCH signaling in multiple myeloma angiogenesis and progression 114
Erythropoietin is involved in the angiogenic potential of bone marrow macrophages in multiple myeloma 111
Role of erythropoietin in the angiogenic activity of bone marrow endothelial cells of MGUS and multiple myeloma patients 110
Filgrastim, lenograstim and pegfilgrastim in the mobilization of peripheral blood progenitor cells in patients with lymphoproliferative malignancies 110
Evidence for bone marrow adult stem cell plasticity: Properties, molecular mechanisms, negative aspects, and clinical applications of hematopoietic and mesenchymal stem cells transdifferentiation 108
Salvage treatment with lenalidomide and dexamethasone in relapsed/refractory mantle cell lymphoma: Clinical results and effects on microenvironment and neo-angiogenic biomarkers 108
Functional and biological role of endothelial precursor cells in tumour progression: A new potential therapeutic target in haematological malignancies 107
Identify multiple myeloma stem cells: Utopia? 107
Suspected Pericardial Tuberculosis Revealed as an Amyloid Pericardial Mass 107
Multiple myeloma macrophages: Pivotal players in the tumor microenvironment 105
Vasculogenic mimicry by bone marrow macrophages in patients with multiple myeloma 104
Dendritic cells accumulate in the bone marrow of myeloma patients where they protect tumor plasma cells from CD8+ T-cell killing 104
Continuous therapy in standard- and high-risk newly-diagnosed multiple myeloma: A pooled analysis of 2 phase III trials 103
null 101
High-Risk Multiple Myeloma: Integrated Clinical and Omics Approach Dissects the Neoplastic Clone and the Tumor Microenvironment 101
"Real world" outcome of lenalidomide plus dexamethasone in the setting of recurrent and refractory multiple myeloma: Extended follow-up of a retrospective multicenter study by the "rete ematologica pugliese" 100
Echocardiographic findings and plasma endothelin-1 levels in obese patients with and without obstructive sleep apnea 99
Neutropenia and G-CSF in lymphoproliferative diseases 99
Recurrent primary plasmacytoma of the eyelid with rapid regional metastasis 99
Novel targeting of phospho-cMET overcomes drug resistance and induces antitumor activity in multiple myeloma 98
Delayed complete remission in a patient with multiple myeloma 97
Prognostic or predictive value of circulating cytokines and angiogenic factors for initial treatment of multiple myeloma in the GIMEMA MM0305 randomized controlled trial 97
Osteolytic lesions, cytogenetic features and bone marrow levels of cytokines and chemokines in multiple myeloma patients: Role of chemokine (C-C motif) ligand 20 96
Fibrinogen apheresis in the treatment of peripheral arterial disease 95
Modifications of the mouse bone marrow microenvironment favor angiogenesis and correlate with disease progression from asymptomatic to symptomatic multiple myeloma. 94
Homotypic and Heterotypic Activation of the Notch Pathway in Multiple Myeloma–Enhanced Angiogenesis: A Novel Therapeutic Target? 94
Vascular Endothelial Growth Factor and its Receptors in Multiple Myeloma 93
Autologous transplant vs oral chemotherapy and lenalidomide in newly diagnosed young myeloma patients: a pooled analysis 92
Metronomic chemotherapy from rationale to clinical studies: A dream or reality? 92
Bone marrow angiogenesis and mast cell density increase simultaneously with progression of human multiple myeloma 91
Halting prosurvival autophagy by TGFβ inhibition in bone marrow fibroblasts overcomes Bortezomid resistance in multiple myeloma patients. 91
Biological activity of substrate-bound basic fibroblast growth factor (FGF2): recruitment of FGF receptor-1 in endothelial cell adhesion contacts 90
Oral melphalan, prednisone, and thalidomide in elderly patients with multiple myeloma: updated results of a randomized controlled trial 89
null 88
Does a reduction of adhesion molecules by LDL-apheresis have a role in the treatment of sudden hearing loss? 88
null 87
Angiogenesis extent and expression of matrix metalloproteinase-2 and -9 correlate with upgrading and myometrial invasion in endometrial carcinoma 87
Is the efficacy of LDL apheresis in ischemic optic neuropathy linked to a reduction in endothelial activation markers? 87
Angiogenesis in multiple myeloma 87
Age and organ damage correlate with poor survival in myeloma patients: Meta-analysis of 1435 individual patient data from 4 randomized trials 87
Proteolytic activity of human lymphoid tumor cells. Correlation with tumor progression 86
Circulating miRNA markers show promise as new prognosticators for multiple myeloma 86
Could multiple myeloma VEGF modify the systemic microcirculation? 84
Bone marrow fibroblasts parallel multiple myeloma progression in patients and mice: In vitro and in vivo studies 82
Treatment Intensification With Autologous Stem Cell Transplantation and Lenalidomide Maintenance Improves Survival Outcomes of Patients With Newly Diagnosed Multiple Myeloma in Complete Response 81
A multiple myeloma that progressed as type i cryoglobulinemia with skin ulcers and foot necrosis: A case report 80
Different Adaptive Responses to Hypoxia in Normal and Multiple Myeloma Endothelial Cells 79
Maintenance in myeloma patients achieving complete response after upfront therapy: a pooled analysis 79
Chemotherapy plus lenalidomide versus autologous transplantation, followed by lenalidomide plus prednisone versus lenalidomide maintenance, in patients with multiple myeloma: A randomised, multicentre, phase 3 trial 79
Endothelial cells in the bone marrow of patients with multiple myeloma 78
Inhibition of mTOR complex 2 restrains tumor angiogenesis in multiple myeloma 78
Efficacy and safety of once weekly bortezomib in multiple myeloma patients 78
An experimental study in the chick embryo chorioallantoic membrane of the anti-angiogenic activity of cyclosporine in rheumatoid arthritis versus osteoarthritis 78
Elotuzumab plus pomalidomide and dexamethasone in relapsed/refractory multiple myeloma: a multicenter, retrospective real-world experience with 200 cases outside of controlled clinical trials 77
Circulating cell adhesion molecules are increased in hypertensive left ventricular hypertrophy 77
null 76
TNP-470 and recombinant human interferon-alpha2a inhibit angiogenesis synergistically 76
null 75
Halting pro-survival autophagy by TGFβ inhibition in bone marrow fibroblasts overcomes bortezomib resistance in multiple myeloma patients 75
Safety and efficacy of bortezomib-melphalan-prednisone-thalidomide followed by bortezomib-thalidomide maintenance (VMPT-VT) versus bortezomib-melphalan-prednisone(VMP) in untreated multiple myeloma patients with renal impairment. 75
High-dose thiotepa, etoposide and carboplatin as conditioning regimen for autologous stem cell transplantation in patients with high-risk Hodgkin's lymphoma 75
Human recombinant interferon alpha-2a inhibits angiogenesis of chick area vasculosa in shell-less culture 74
Angiogenesis and progression in human melanoma 74
Cross-talk between hematopoiesis and angiogenesis signaling pathways 74
Pentraxin 3 (PTX3) inhibits plasma cell/stromal cell cross-talk in the bone marrow of multiple myeloma patients 73
In vivo time-course of the angiogenic response induced by multiple myeloma plasma cells in the chick embryo chorioallantoic membrane 73
Effect of low-density lipoprotein apheresis on circulating endothelial progenitor cells in familial hypercholesterolemia 72
High-dose thiotepa, etoposide and carboplatin as conditioning regimen for autologous stem cell transplantation in patients with high-risk non-Hodgkin lymphoma 72
Human lymphoblastoid cells produce extracellular matrix-degrading enzymes and induce endothelial cell proliferation, migration, morphogenesis, and angiogenesis 72
Development of vasculature targeting strategies for the treatment of chronic inflammatory diseases 71
Angiogenesis extent and macrophage density increase simultaneously with pathological progression in B-cell non-Hodgkin’s lymphomas 71
null 71
Monoclonal gammopathy as a marker of primary cerebral lymphoma 70
Lenalidomide restrains motility and overangiogenic potential of bone marrow endothelial cells in patients with active multiple myeloma 70
Cancer-related coagulopathy (Trousseau's syndrome): Review of the literature and experience of a single center of internal medicine 70
Bendamustine, Low-dose dexamethasone, and lenalidomide (BdL) for the treatment of patients with relapsed/refractory multiple myeloma confirms very promising results in a phase I/II study 70
Systemic sclerosis stimulates angiogenesis in the chick embryo chorioallantoic membrane 69
Bone marrow dendritic cells induce myeloma cell resistance to CD8+ T cell-mediated killing 69
Long-term effects of tibolone on circulating levels of vascular cell adhesion molecules and E-selectin in postmenopausal women 68
Is re-challenge still an option as salvage therapy in multiple myeloma? The case of REal-life BOrtezomib re-Use as secoND treatment for relapsed patients exposed frontline to bortezomib-based therapies (the REBOUND Study) 68
Salvage therapy with thalidomide in patients with advanced relapsed/refractory multiple myeloma 68
Angiogenesi midollare e molecole di adesione per l’endotelio nei pazienti con mieloma multiplo (MM) e con gammapatia monoclonale non mielomatosa (MGUS) 67
Mast cell contribution to angiogenesis related to tumour progression 67
Role of angiogenesis and microenvironment in melanoma progression 67
A weekly infusion of bortezomib reduces peripheral neuropathy 67
null 67
Bortezomib treatment modulates autophagy in multiple myeloma 67
Effects of severe hypertension on soluble cellular adhesion molecule levels 66
Role of stromal cells in neovascularization of multiple myeloma 66
null 66
Bone marrow angiogenesis and plasma cell angiogenic and invasive potential in patients with active multiple myeloma 66
Serum Free Light Chains in Common Variable Immunodeficiency Disorders: Role in Differential Diagnosis and Association With Clinical Phenotype 66
Angiogenesi e progressione tumorale nel melanoma 65
90y-ibritumomab tiuxetan as consolidation therapy after autologous stem cell trasplantation in aggressive non-Hodgkin lymphoma 65
Halting the vicious cycle within the multiple myeloma ecosystem: blocking JAM-A on bone marrow endothelial cells restores the angiogenic homeostasis and suppresses tumor progression 65
Totale 8.648
Salva come PNG Salva come JPEG
Categoria #
all - tutte 61.145
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 61.145
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.984 0 181 107 287 360 252 369 352 478 200 272 126
2020/20212.575 175 157 183 151 370 190 205 200 182 335 254 173
2021/20221.639 153 203 17 52 63 106 92 84 95 122 272 380
2022/20232.914 381 304 185 283 339 423 22 308 532 22 57 58
2023/20241.188 100 196 72 60 106 329 60 75 7 22 30 131
2024/2025203 127 76 0 0 0 0 0 0 0 0 0 0
Totale 14.307